Integrative analyses of high-throughput 'omic data, such as DNA methylation, DNA copy number alteration, mRNA and protein expression levels, have created unprecedented opportunities to understand the molecular basis of human disease. In particular, integrative analyses have been the cornerstone in the study of cancer to determine molecular subtypes within a given cancer. As malignant tumors with similar morphological characteristics have been shown to exhibit entirely different molecular profiles, there has been significant interest in using multiple 'omic data for the identification of novel molecular subtypes of disease, which could impact treatment decisions. Therefore, we have developed intNMF, an integrative approach for disease subtyp...
Scope In biomedical research, mass spectrometry imaging (MSI) can obtain spatially-resolved molecula...
Cancer is a heterogeneity genetic disease with huge phenotypic alterations among dissimilar cancers ...
The molecular complexity of a tumor manifests itself at the genomic, epigenomic, transcriptomic, and...
Motivation: The integration of multi-omic data by using machine learning methods has been focused to...
Advances in high-throughput technologies allow for measurements of many types of omics data, yet the...
The multi-modal or multi-view integration of data has generated a wide range of applicability in pat...
Recent technological advances and international efforts, such as The Cancer Genome Atlas (TCGA), hav...
International audienceMotivation:It is more and more common to explore the genome at diverse levels ...
Motivation: Subtyping cancer is key to an improved and more personalized prognosis/treatment. The in...
Integrative clustering is used to identify groups of samples by jointly analysing multiple datasets ...
International audienceThe generation of multi-omics data is growing with the improvement of high-thr...
Cancer genomic data contain views from different sources that provide complementary information abou...
Identification and prediction of cancer subtypes are important parts in the development towards pers...
BackgroundComprehensive molecular profiling has revealed somatic variations in cancer at genomic, ep...
Non-negative matrix factorization (NMF) is a relatively new approach to analyze gene expression data...
Scope In biomedical research, mass spectrometry imaging (MSI) can obtain spatially-resolved molecula...
Cancer is a heterogeneity genetic disease with huge phenotypic alterations among dissimilar cancers ...
The molecular complexity of a tumor manifests itself at the genomic, epigenomic, transcriptomic, and...
Motivation: The integration of multi-omic data by using machine learning methods has been focused to...
Advances in high-throughput technologies allow for measurements of many types of omics data, yet the...
The multi-modal or multi-view integration of data has generated a wide range of applicability in pat...
Recent technological advances and international efforts, such as The Cancer Genome Atlas (TCGA), hav...
International audienceMotivation:It is more and more common to explore the genome at diverse levels ...
Motivation: Subtyping cancer is key to an improved and more personalized prognosis/treatment. The in...
Integrative clustering is used to identify groups of samples by jointly analysing multiple datasets ...
International audienceThe generation of multi-omics data is growing with the improvement of high-thr...
Cancer genomic data contain views from different sources that provide complementary information abou...
Identification and prediction of cancer subtypes are important parts in the development towards pers...
BackgroundComprehensive molecular profiling has revealed somatic variations in cancer at genomic, ep...
Non-negative matrix factorization (NMF) is a relatively new approach to analyze gene expression data...
Scope In biomedical research, mass spectrometry imaging (MSI) can obtain spatially-resolved molecula...
Cancer is a heterogeneity genetic disease with huge phenotypic alterations among dissimilar cancers ...
The molecular complexity of a tumor manifests itself at the genomic, epigenomic, transcriptomic, and...